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MEDLINE was searched for English language journal articles from 1966 to 1994 addressing the techniques for the diagnosis of catheter-related infections. Review articles, textbook chapters and references in MEDLINE were also searched.
Criteria used to ensure the validity of primary studies
Only studies supplying primary data and using epidemiologic study methods similar enough to be statistically grouped by diagnostic test method were included in the review.
Methods used to judge relevance and validity, and for extracting data
All studies were reviewed by at least two authors, and decisions regarding exclusion were made by consensus of the authors. Primary data published in individual studies were used. Studies that could not be pooled due to differences in technique were not pooled.
Number of primary studies included
22 primary studies were included in the review.
Methods of combining primary studies
A meta-analysis was conducted to obtain pooled sensitivity and specificity characteristics, by simple pooling of the primary data from individual studies for each one of the six diagnostic methods. Studies were not weighted.
Investigation of differences between primary studies
The authors investigated alternative explanations of the accuracy of test results (such as the variable pathogenesis of catheter related bloodstream infection). The possibility existed of incorporation bias in some of the studies and this could compromise the validity of the results, by inflating the accuracy of the tests. The small number of studies available for each test method limited the statistical power to assess the dependence of accuracy on study quality versus patient characteristics and test threshold. Statistical tests for homogeneity were conducted for the pooled sensitivity and specificity results. Specificity was heterogeneous for all six methods. Sensitivity was heterogeneous in 4 out 6 methods.
Results of the review
Qualitative catheter segment culture had 95% sensitivity and 75% specificity. Semi-quantitative catheter culture had 85% sensitivity and 85% specificity. Quantitative catheter segment culture had 94% sensitivity and 92% specificity. The unpaired qualitative catheter blood culture method had 91% sensitivity and 86% specificity. The unpaired quantitative catheter blood culture method had 78% sensitivity and 96% specificity. Paired quantitative blood culture methods had 79% sensitivity and 94% specificity. For the blood culture from catheter methods, the mean Youden index was 3.86 (unpaired qualitative), 4.41 (unpaired quantitative) and 4.98 (paired quantitative). These were the principal results used to derive an estimate of benefit (correct diagnoses).
Synthesis of costs and benefits
The estimated costs and benefits were combined to obtain a cost per accurate test result, using the cost of the test and the pooled sensitivity and specificity of the tests. The calculation involved the assumptions that the prevalence of catheter-related bloodstream infection among febrile patients was 10%, that two sets of peripheral blood cultures would be drawn for each patient, and that patients with false positive test results for blood cultures drawn from the catheter would receive antibiotic therapy for an average of 10 days.
No costs were added for infectious complications related to false negative tests.
The estimated costs per accurate test were as follows: 
Authors' conclusions
The test with the lowest cost to the entire hospital per accurate test result was the unpaired quantitative catheter blood culture. Among catheter segment cultures, the semi-quantitative method was the most cost-effective.
CRD COMMENTARY -Selection of comparators
The rationale for the selection of the different tests was clear. However, the authors' search of the literature revealed a total of 16 test procedures and 17 variations, and therefore all possible comparators were not included in the analysis.
Validity of estimate of measure of benefit
The implicit measure of benefit was the number of people correctly diagnosed, obtained by using sensitivity and specificity results of the meta-analysis and assuming a 10% prevalence of the disease. A sensitivity analysis on these three parameters would have strengthened the analysis, given that the source of the prevalence estimate was not referenced and that some of the pooled sensitivity and specificity estimates needed to be considered with caution because of the presence of heterogeneity. The issue of other possible alternatives (see Selection of Comparators above) meant that other, more effective strategies may exist which could not be addressed in the present study due to lack of available analyses suitable for inclusion.
Validity of estimate of costs
The source of some of the costs was not referenced and no sensitivity analysis was conducted on the cost estimates. The lack of price year and use of local data limits the generalisability of the results to other settings.
Other issues
The cost-effectiveness analysis could have been strengthened by more detailed information on the calculation of the cost per accurate test. Although the authors stated that these costs represented the cost to the entire hospital, this is unlikely since the costs of not treating false negatives were not included. However such an analysis would require using a more complex measure of benefits. Comparison of results from other studies on diagnostic methods have corroborated the results of the meta-analysis. However, the authors did not mention any other cost-effectiveness studies of diagnostic methods for catheter-related bloodstream infection. Improved generalisability of the study results would require sensitivity analysis to be conducted on the costs of the tests and the prevalence of the disease. Finally, an incremental analysis should have been performed rather than reporting average costs per accurate test, as average costs tend to be misleading by producing favourable results for low cost alternatives with low effectiveness.
